Skip to main content
FinSpry Logo
FinSpry
LSTA logo
LSTA
(NASDAQ)
Lisata Therapeutics, Inc.
$5.02-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lisata Therapeutics (LSTA) Stock Price & Financial Analysis

Lisata Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.01 - $5.03
52-Week High$5.07
52-Week Low$1.81
Open$5.01
Volume15.32K
Average Volume (3M)15.32K
Market Cap43.86M
Shares Outstanding8.74M
Price to Sales (P/S)40.91
Price to Book (P/B)2.52
EV/EBITDA-1.24
Revenue (TTM)1.07M
Net Income (TTM)-18.24M
Free Cash Flow (TTM)-17.28M
EPS (TTM)$-2.09
Profit Margin-1704.86%
Operating Margin-1876.45%
Return on Equity (ROE)-105.00%
Debt to Equity0.00
50-Day MA$4.64
200-Day MA$2.93
52-Week Change131.94%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateOct 28, 2013

Frequently Asked Questions About Lisata Therapeutics

What is the current stock price for LSTA?

As of the latest trading session, LSTA stock trades at $5.02. The 52-week range is $1.81–$5.07, with a day range of $5.01–$5.03.

What is the P/E ratio for LSTA?

The P/E ratio (Price-to-Earnings) for LSTA is shown in the Key Statistics section. This valuation metric helps compare Lisata Therapeutics, Inc. to industry peers.

Does LSTA pay dividends?

Lisata Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LSTA?

Based on 1 analyst, the consensus for LSTA is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LSTA?

Lisata Therapeutics's market capitalization is $43.9M, classifying it as a micro-cap company. Lisata Therapeutics operates in the Healthcare sector within the Biotechnology industry.